在接受放射治疗的癌症患者中,数字支持和人工智能:患者利用,接受和态度
Franziska Springer1, Peter Kurt Hambsch2, Anja Mehnert-Theuerkauf1
1Department of Medical Psychology and Medical Sociology, Comprehensive Cancer Center Central Germany (CCCG), University Medical Center, Leipzig, Germany.
Frontiers in oncology
|October 13, 2025
概括
癌症患者对数字工具和人工智能持开放态度,但感到缺乏信息. 老年患者,社会经济地位较低的患者和有限的数字健康素养显示出对这些技术的信任和利用程度较低.
科学领域:
- 在瘤学瘤学.
- 数字健康数字健康
- 人工智能的人工智能
背景情况:
- 关于患者对癌症护理新技术的态度的证据有限.
- 数字支持工具和人工智能为癌症诊断和治疗提供了新的途径.
- 患者的观点对于有效整合这些创新至关重要.
研究的目的:
- 研究癌症患者对数字支持工具和人工智能的利用,接受和态度.
- 确定与采用这些技术相关的患者相关因素.
- 了解患者对癌症护理技术的关注和偏好.
主要方法:
- 探索性观察性横截面研究设计.
- 包括接受放射治疗的成年癌症患者.
- 利用经过验证的问卷和新开发的项目来评估技术的接受和态度.
主要成果:
- 患者普遍认为他们对数字支持工具 (12%) 和人工智能 (16%) 缺乏了解.
- 一半的患者使用了数字支持工具,65%的人认为它们是有益的,79%的人对人工智能持开放态度.
- 老年患者,社会经济地位较低的患者和有限的数字健康素养 (DHL) 表明对新技术的使用和信任较低.
结论:
- 患者对人工智能持开放态度,但仍有担忧,这凸显了医生监督负责任实施的必要性.
- 提高数字健康素养 (DHL),信息提供和弱势群体的访问是必不可少的.
- 新技术的有效整合需要解决患者的担忧,并确保公平的获取.
相关概念视频
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Issues And Trends In Healthcare Delivery System
6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


